nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Tonic-clonic seizures—Carmustine—malignant glioma	0.0275	0.0941	CcSEcCtD
Vidarabine—DPP4—blood vessel—malignant glioma	0.0224	0.134	CbGeAlD
Vidarabine—Intracranial pressure increased—Carmustine—malignant glioma	0.0177	0.0607	CcSEcCtD
Vidarabine—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0174	0.0597	CcSEcCtD
Vidarabine—Grand mal convulsion—Carmustine—malignant glioma	0.0155	0.0533	CcSEcCtD
Vidarabine—DPP4—embryo—malignant glioma	0.0134	0.0798	CbGeAlD
Vidarabine—ADORA2A—telencephalon—malignant glioma	0.0125	0.0745	CbGeAlD
Vidarabine—Adenosine monophosphate—PIM1—malignant glioma	0.0122	0.277	CrCbGaD
Vidarabine—ADK—retina—malignant glioma	0.0122	0.0728	CbGeAlD
Vidarabine—ADK—telencephalon—malignant glioma	0.0112	0.0669	CbGeAlD
Vidarabine—Burning sensation—Carmustine—malignant glioma	0.0107	0.0365	CcSEcCtD
Vidarabine—Scotoma—Carmustine—malignant glioma	0.00974	0.0334	CcSEcCtD
Vidarabine—Scotoma—Temozolomide—malignant glioma	0.00942	0.0323	CcSEcCtD
Vidarabine—Glucosamine—IFNG—malignant glioma	0.00926	0.21	CrCbGaD
Vidarabine—Adenosine triphosphate—ACVR1—malignant glioma	0.00901	0.204	CrCbGaD
Vidarabine—ADK—medulla oblongata—malignant glioma	0.00882	0.0526	CbGeAlD
Vidarabine—ADORA2A—spinal cord—malignant glioma	0.00875	0.0522	CbGeAlD
Vidarabine—ADK—midbrain—malignant glioma	0.00806	0.0481	CbGeAlD
Vidarabine—ADK—spinal cord—malignant glioma	0.00786	0.0469	CbGeAlD
Vidarabine—ADA—central nervous system—malignant glioma	0.00781	0.0466	CbGeAlD
Vidarabine—Injection site reaction—Carmustine—malignant glioma	0.00736	0.0252	CcSEcCtD
Vidarabine—Respiratory failure—Temozolomide—malignant glioma	0.00728	0.0249	CcSEcCtD
Vidarabine—ADORA2A—central nervous system—malignant glioma	0.0071	0.0424	CbGeAlD
Vidarabine—ADORA2A—cerebellum—malignant glioma	0.00694	0.0414	CbGeAlD
Vidarabine—ADK—central nervous system—malignant glioma	0.00638	0.038	CbGeAlD
Vidarabine—ADK—cerebellum—malignant glioma	0.00623	0.0372	CbGeAlD
Vidarabine—ADA—brain—malignant glioma	0.0062	0.037	CbGeAlD
Vidarabine—DPP4—central nervous system—malignant glioma	0.00618	0.0369	CbGeAlD
Vidarabine—Glucosamine—MMP9—malignant glioma	0.0059	0.134	CrCbGaD
Vidarabine—Nasal congestion—Temozolomide—malignant glioma	0.0057	0.0195	CcSEcCtD
Vidarabine—ADORA2A—brain—malignant glioma	0.00564	0.0336	CbGeAlD
Vidarabine—Affect lability—Temozolomide—malignant glioma	0.00511	0.0175	CcSEcCtD
Vidarabine—ADK—brain—malignant glioma	0.00506	0.0302	CbGeAlD
Vidarabine—Mood swings—Temozolomide—malignant glioma	0.00492	0.0168	CcSEcCtD
Vidarabine—DPP4—brain—malignant glioma	0.00491	0.0293	CbGeAlD
Vidarabine—Pollakiuria—Temozolomide—malignant glioma	0.00414	0.0142	CcSEcCtD
Vidarabine—Glucosamine—TNF—malignant glioma	0.00388	0.088	CrCbGaD
Vidarabine—Adenosine triphosphate—AKT1—malignant glioma	0.0038	0.0862	CrCbGaD
Vidarabine—Hypoaesthesia—Carmustine—malignant glioma	0.0037	0.0127	CcSEcCtD
Vidarabine—Hypoaesthesia—Temozolomide—malignant glioma	0.00357	0.0122	CcSEcCtD
Vidarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.00356	0.00718	CbGpPWpGaD
Vidarabine—ADK—Metabolism—RTEL1—malignant glioma	0.00349	0.00704	CbGpPWpGaD
Vidarabine—Flushing—Carmustine—malignant glioma	0.00345	0.0118	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—NTRK3—malignant glioma	0.00344	0.00693	CbGpPWpGaD
Vidarabine—Tinnitus—Temozolomide—malignant glioma	0.00335	0.0115	CcSEcCtD
Vidarabine—Cardiac disorder—Temozolomide—malignant glioma	0.00333	0.0114	CcSEcCtD
Vidarabine—Flushing—Temozolomide—malignant glioma	0.00333	0.0114	CcSEcCtD
Vidarabine—Arrhythmia—Carmustine—malignant glioma	0.00332	0.0114	CcSEcCtD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—malignant glioma	0.00329	0.00662	CbGpPWpGaD
Vidarabine—Mediastinal disorder—Temozolomide—malignant glioma	0.00324	0.0111	CcSEcCtD
Vidarabine—ADA—Validated transcriptional targets of TAp63 isoforms—MDM2—malignant glioma	0.00319	0.00643	CbGpPWpGaD
Vidarabine—Back pain—Carmustine—malignant glioma	0.00313	0.0107	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—PML—malignant glioma	0.00307	0.00618	CbGpPWpGaD
Vidarabine—Dysgeusia—Temozolomide—malignant glioma	0.00306	0.0105	CcSEcCtD
Vidarabine—Vision blurred—Carmustine—malignant glioma	0.00305	0.0104	CcSEcCtD
Vidarabine—Tremor—Carmustine—malignant glioma	0.00303	0.0104	CcSEcCtD
Vidarabine—Back pain—Temozolomide—malignant glioma	0.00302	0.0104	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Other—CXCR3—malignant glioma	0.00298	0.006	CbGpPWpGaD
Vidarabine—Agitation—Carmustine—malignant glioma	0.00297	0.0102	CcSEcCtD
Vidarabine—Vision blurred—Temozolomide—malignant glioma	0.00295	0.0101	CcSEcCtD
Vidarabine—Tremor—Temozolomide—malignant glioma	0.00293	0.01	CcSEcCtD
Vidarabine—Agitation—Temozolomide—malignant glioma	0.00287	0.00984	CcSEcCtD
Vidarabine—Angioedema—Temozolomide—malignant glioma	0.00286	0.00979	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—TOP2A—malignant glioma	0.0028	0.00565	CbGpPWpGaD
Vidarabine—Convulsion—Carmustine—malignant glioma	0.0028	0.0096	CcSEcCtD
Vidarabine—Hypertension—Carmustine—malignant glioma	0.00279	0.00957	CcSEcCtD
Vidarabine—Palpitations—Temozolomide—malignant glioma	0.00276	0.00947	CcSEcCtD
Vidarabine—Chest pain—Carmustine—malignant glioma	0.00275	0.00944	CcSEcCtD
Vidarabine—Anxiety—Carmustine—malignant glioma	0.00274	0.0094	CcSEcCtD
Vidarabine—Cough—Temozolomide—malignant glioma	0.00273	0.00935	CcSEcCtD
Vidarabine—Convulsion—Temozolomide—malignant glioma	0.00271	0.00928	CcSEcCtD
Vidarabine—Hypertension—Temozolomide—malignant glioma	0.0027	0.00925	CcSEcCtD
Vidarabine—Anxiety—Temozolomide—malignant glioma	0.00265	0.00909	CcSEcCtD
Vidarabine—Discomfort—Temozolomide—malignant glioma	0.00263	0.00901	CcSEcCtD
Vidarabine—Dry mouth—Temozolomide—malignant glioma	0.0026	0.00892	CcSEcCtD
Vidarabine—Tachycardia—Carmustine—malignant glioma	0.00258	0.00883	CcSEcCtD
Vidarabine—Anaphylactic shock—Temozolomide—malignant glioma	0.00255	0.00874	CcSEcCtD
Vidarabine—ADORA2A—Monoamine Transport—IL1B—malignant glioma	0.0025	0.00503	CbGpPWpGaD
Vidarabine—Hypotension—Carmustine—malignant glioma	0.00247	0.00845	CcSEcCtD
Vidarabine—Hyperhidrosis—Temozolomide—malignant glioma	0.00247	0.00845	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00241	0.00824	CcSEcCtD
Vidarabine—ADA—Metabolism—RTEL1—malignant glioma	0.00238	0.00479	CbGpPWpGaD
Vidarabine—Paraesthesia—Carmustine—malignant glioma	0.00237	0.00812	CcSEcCtD
Vidarabine—Dyspnoea—Carmustine—malignant glioma	0.00235	0.00806	CcSEcCtD
Vidarabine—ADA—p73 transcription factor network—MDM2—malignant glioma	0.00235	0.00474	CbGpPWpGaD
Vidarabine—Somnolence—Carmustine—malignant glioma	0.00235	0.00804	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00232	0.00796	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—CDKN2A—malignant glioma	0.00231	0.00465	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—XBP1—malignant glioma	0.0023	0.00462	CbGpPWpGaD
Vidarabine—Paraesthesia—Temozolomide—malignant glioma	0.00229	0.00785	CcSEcCtD
Vidarabine—Dyspnoea—Temozolomide—malignant glioma	0.00227	0.00779	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—BCL2—malignant glioma	0.00227	0.00458	CbGpPWpGaD
Vidarabine—Somnolence—Temozolomide—malignant glioma	0.00227	0.00777	CcSEcCtD
Vidarabine—Pain—Carmustine—malignant glioma	0.00226	0.00774	CcSEcCtD
Vidarabine—Pain—Temozolomide—malignant glioma	0.00218	0.00748	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—NTRK1—malignant glioma	0.00218	0.00439	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—PTGS2—malignant glioma	0.00216	0.00435	CbGpPWpGaD
Vidarabine—Urticaria—Temozolomide—malignant glioma	0.00203	0.00694	CcSEcCtD
Vidarabine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	0.00201	0.00406	CbGpPWpGaD
Vidarabine—ADK—Metabolism—COX8A—malignant glioma	0.00201	0.00404	CbGpPWpGaD
Vidarabine—Hypersensitivity—Carmustine—malignant glioma	0.00194	0.00666	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—NCOR1—malignant glioma	0.00191	0.00384	CbGpPWpGaD
Vidarabine—Asthenia—Carmustine—malignant glioma	0.00189	0.00649	CcSEcCtD
Vidarabine—Hypersensitivity—Temozolomide—malignant glioma	0.00188	0.00644	CcSEcCtD
Vidarabine—Asthenia—Temozolomide—malignant glioma	0.00183	0.00627	CcSEcCtD
Vidarabine—ADORA2A—Monoamine Transport—TNF—malignant glioma	0.00181	0.00365	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PML—malignant glioma	0.00176	0.00355	CbGpPWpGaD
Vidarabine—Dizziness—Carmustine—malignant glioma	0.00175	0.00598	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00174	0.00351	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ASMT—malignant glioma	0.00171	0.00344	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—SPHK1—malignant glioma	0.0017	0.00343	CbGpPWpGaD
Vidarabine—Dizziness—Temozolomide—malignant glioma	0.00169	0.00578	CcSEcCtD
Vidarabine—Vomiting—Carmustine—malignant glioma	0.00168	0.00575	CcSEcCtD
Vidarabine—Rash—Carmustine—malignant glioma	0.00166	0.0057	CcSEcCtD
Vidarabine—Dermatitis—Carmustine—malignant glioma	0.00166	0.0057	CcSEcCtD
Vidarabine—Headache—Carmustine—malignant glioma	0.00165	0.00567	CcSEcCtD
Vidarabine—ADA—p73 transcription factor network—MYC—malignant glioma	0.00164	0.00331	CbGpPWpGaD
Vidarabine—Vomiting—Temozolomide—malignant glioma	0.00162	0.00556	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—TOP2A—malignant glioma	0.00161	0.00324	CbGpPWpGaD
Vidarabine—Rash—Temozolomide—malignant glioma	0.00161	0.00551	CcSEcCtD
Vidarabine—Dermatitis—Temozolomide—malignant glioma	0.00161	0.00551	CcSEcCtD
Vidarabine—ADK—Metabolism—BCAN—malignant glioma	0.0016	0.00323	CbGpPWpGaD
Vidarabine—Headache—Temozolomide—malignant glioma	0.0016	0.00548	CcSEcCtD
Vidarabine—Nausea—Carmustine—malignant glioma	0.00157	0.00537	CcSEcCtD
Vidarabine—ADA—C-MYB transcription factor network—MYC—malignant glioma	0.00156	0.00315	CbGpPWpGaD
Vidarabine—Nausea—Temozolomide—malignant glioma	0.00152	0.00519	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—malignant glioma	0.00151	0.00303	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—DUSP6—malignant glioma	0.00149	0.00301	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00149	0.003	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—KRAS—malignant glioma	0.00145	0.00291	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PPARG—malignant glioma	0.00137	0.00275	CbGpPWpGaD
Vidarabine—ADA—Metabolism—COX8A—malignant glioma	0.00136	0.00275	CbGpPWpGaD
Vidarabine—ADK—Metabolism—IDH2—malignant glioma	0.00129	0.00261	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00129	0.00261	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NTRK1—malignant glioma	0.00125	0.00252	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—malignant glioma	0.00123	0.00247	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2B6—malignant glioma	0.00122	0.00245	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00118	0.00238	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—BCHE—malignant glioma	0.00117	0.00237	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ASMT—malignant glioma	0.00116	0.00234	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—YWHAE—malignant glioma	0.00116	0.00233	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NTRK2—malignant glioma	0.00116	0.00233	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—FBXW7—malignant glioma	0.00116	0.00233	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—DUSP6—malignant glioma	0.00115	0.00231	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR4—malignant glioma	0.00114	0.00229	CbGpPWpGaD
Vidarabine—ADK—Metabolism—IDH1—malignant glioma	0.00111	0.00224	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00111	0.00223	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NCOR1—malignant glioma	0.00109	0.00221	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BCAN—malignant glioma	0.00109	0.0022	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SPHK1—malignant glioma	0.00108	0.00217	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2C18—malignant glioma	0.00105	0.00212	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFRA—malignant glioma	0.00103	0.00207	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00101	0.00204	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LATS2—malignant glioma	0.00097	0.00195	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NTRK1—malignant glioma	0.000944	0.0019	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PTEN—malignant glioma	0.000937	0.00189	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFB—malignant glioma	0.000923	0.00186	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000922	0.00186	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR1—malignant glioma	0.000919	0.00185	CbGpPWpGaD
Vidarabine—ADA—Metabolism—IDH2—malignant glioma	0.000879	0.00177	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTT1—malignant glioma	0.000853	0.00172	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCR3—malignant glioma	0.000844	0.0017	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2B6—malignant glioma	0.000827	0.00167	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—malignant glioma	0.000823	0.00166	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS1—malignant glioma	0.000799	0.00161	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD80—malignant glioma	0.000798	0.00161	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PDGFRA—malignant glioma	0.000791	0.00159	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGF—malignant glioma	0.000788	0.00159	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—malignant glioma	0.000784	0.00158	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTPN11—malignant glioma	0.000783	0.00158	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—BDKRB2—malignant glioma	0.000772	0.00155	CbGpPWpGaD
Vidarabine—ADA—Metabolism—IDH1—malignant glioma	0.000756	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—malignant glioma	0.000749	0.00151	CbGpPWpGaD
Vidarabine—ADK—Metabolism—BCHE—malignant glioma	0.000743	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LATS1—malignant glioma	0.000735	0.00148	CbGpPWpGaD
Vidarabine—ADK—Metabolism—SLC5A5—malignant glioma	0.000734	0.00148	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SPHK1—malignant glioma	0.000732	0.00147	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT2—malignant glioma	0.000729	0.00147	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2C18—malignant glioma	0.000717	0.00144	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PDGFB—malignant glioma	0.00071	0.00143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGFR1—malignant glioma	0.000706	0.00142	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—KNG1—malignant glioma	0.000702	0.00141	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CD—malignant glioma	0.000701	0.00141	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF2—malignant glioma	0.000671	0.00135	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—F2—malignant glioma	0.000667	0.00134	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR4—malignant glioma	0.000642	0.00129	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TP53—malignant glioma	0.00064	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BAD—malignant glioma	0.000633	0.00128	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—malignant glioma	0.000628	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RAF1—malignant glioma	0.000626	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—malignant glioma	0.000619	0.00125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CD80—malignant glioma	0.000614	0.00124	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CB—malignant glioma	0.000611	0.00123	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGF—malignant glioma	0.000606	0.00122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PTPN11—malignant glioma	0.000602	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000596	0.0012	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTP1—malignant glioma	0.000591	0.00119	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR4—malignant glioma	0.000583	0.00117	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTT1—malignant glioma	0.00058	0.00117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—BRAF—malignant glioma	0.000576	0.00116	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAT—malignant glioma	0.000575	0.00116	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP2—malignant glioma	0.000565	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT2—malignant glioma	0.000561	0.00113	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NCOR1—malignant glioma	0.000543	0.00109	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS1—malignant glioma	0.000543	0.00109	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CD—malignant glioma	0.000539	0.00109	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PTEN—malignant glioma	0.000538	0.00108	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—malignant glioma	0.000528	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—FGF2—malignant glioma	0.000516	0.00104	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BCHE—malignant glioma	0.000505	0.00102	CbGpPWpGaD
Vidarabine—ADA—Metabolism—SLC5A5—malignant glioma	0.000499	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MDK—malignant glioma	0.000497	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MDM2—malignant glioma	0.000483	0.000972	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RAF1—malignant glioma	0.000481	0.000969	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCR3—malignant glioma	0.000477	0.000961	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ERBB2—malignant glioma	0.000476	0.000959	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DTX1—malignant glioma	0.000474	0.000954	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—malignant glioma	0.000472	0.000951	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—malignant glioma	0.00047	0.000946	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CB—malignant glioma	0.00047	0.000946	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—F2—malignant glioma	0.000454	0.000914	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—malignant glioma	0.000443	0.000892	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—BDKRB2—malignant glioma	0.000436	0.000879	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR3—malignant glioma	0.000433	0.000872	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CASP3—malignant glioma	0.000432	0.00087	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—malignant glioma	0.000429	0.000864	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00042	0.000846	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PTEN—malignant glioma	0.000406	0.000818	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—malignant glioma	0.000405	0.000816	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CG—malignant glioma	0.000403	0.000812	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTP1—malignant glioma	0.000402	0.000809	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—KNG1—malignant glioma	0.000397	0.000799	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—BDKRB2—malignant glioma	0.000396	0.000798	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAT—malignant glioma	0.000391	0.000788	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—malignant glioma	0.000389	0.000784	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SUFU—malignant glioma	0.000376	0.000758	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—malignant glioma	0.000372	0.00075	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HEY2—malignant glioma	0.000372	0.000749	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NCOR1—malignant glioma	0.000369	0.000744	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—malignant glioma	0.000367	0.00074	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GFAP—malignant glioma	0.000363	0.000731	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—malignant glioma	0.000363	0.000731	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KNG1—malignant glioma	0.00036	0.000726	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CD—malignant glioma	0.000355	0.000714	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPHK1—malignant glioma	0.000351	0.000708	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HEY1—malignant glioma	0.000344	0.000693	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR4—malignant glioma	0.000344	0.000693	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HIST1H3B—malignant glioma	0.000334	0.000674	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—malignant glioma	0.00033	0.000665	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—malignant glioma	0.00032	0.000644	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MMP3—malignant glioma	0.000319	0.000643	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—KRAS—malignant glioma	0.000312	0.000628	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CB—malignant glioma	0.000309	0.000623	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—malignant glioma	0.000306	0.000617	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—JAG2—malignant glioma	0.000305	0.000615	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—malignant glioma	0.000304	0.000613	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—malignant glioma	0.000301	0.000606	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PIK3CA—malignant glioma	0.000286	0.000577	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CG—malignant glioma	0.000274	0.000552	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTEN—malignant glioma	0.000267	0.000538	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—malignant glioma	0.000265	0.000533	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—H3F3A—malignant glioma	0.000258	0.00052	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2—malignant glioma	0.000256	0.000517	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR3—malignant glioma	0.000256	0.000515	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—YWHAE—malignant glioma	0.000249	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK2—malignant glioma	0.000249	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FLT1—malignant glioma	0.000248	0.000499	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—DUSP6—malignant glioma	0.000247	0.000497	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CG—malignant glioma	0.000245	0.000494	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—JAG1—malignant glioma	0.000244	0.000491	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH3—malignant glioma	0.000243	0.000488	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CD—malignant glioma	0.000241	0.000485	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FBXW7—malignant glioma	0.000239	0.000481	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB2—malignant glioma	0.000234	0.000471	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—malignant glioma	0.000234	0.000471	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2—malignant glioma	0.000233	0.000469	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT2—malignant glioma	0.000225	0.000452	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CG—malignant glioma	0.000223	0.000449	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PTPN11—malignant glioma	0.000219	0.000441	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH2—malignant glioma	0.000218	0.000438	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CD—malignant glioma	0.000216	0.000435	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KNG1—malignant glioma	0.000213	0.000429	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CB—malignant glioma	0.00021	0.000423	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—malignant glioma	0.000208	0.000419	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT2—malignant glioma	0.000204	0.000411	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK1—malignant glioma	0.000203	0.000409	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CD—malignant glioma	0.000196	0.000395	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP3—malignant glioma	0.000189	0.00038	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PIK3CA—malignant glioma	0.000188	0.000379	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CB—malignant glioma	0.000188	0.000379	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDKN2B—malignant glioma	0.000187	0.000377	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2—malignant glioma	0.000182	0.000366	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTEN—malignant glioma	0.000182	0.000366	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—malignant glioma	0.000181	0.000364	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HES1—malignant glioma	0.000178	0.000359	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCOR1—malignant glioma	0.000177	0.000357	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RAF1—malignant glioma	0.000175	0.000352	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2—malignant glioma	0.000173	0.000348	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CB—malignant glioma	0.000171	0.000344	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFRA—malignant glioma	0.00017	0.000342	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPP1—malignant glioma	0.000165	0.000332	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—malignant glioma	0.000164	0.000331	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2—malignant glioma	0.000157	0.000316	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TERT—malignant glioma	0.000156	0.000315	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—malignant glioma	0.000154	0.00031	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFB—malignant glioma	0.000153	0.000307	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGFR1—malignant glioma	0.000152	0.000306	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HIF1A—malignant glioma	0.000149	0.000301	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—malignant glioma	0.000145	0.000291	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KDR—malignant glioma	0.000143	0.000288	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2—malignant glioma	0.000138	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—malignant glioma	0.000138	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BAD—malignant glioma	0.000136	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH1—malignant glioma	0.000135	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD80—malignant glioma	0.000132	0.000266	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CG—malignant glioma	0.000132	0.000265	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APC—malignant glioma	0.000132	0.000265	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGF—malignant glioma	0.00013	0.000262	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTPN11—malignant glioma	0.000129	0.000261	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PIK3CA—malignant glioma	0.000128	0.000258	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BRAF—malignant glioma	0.000124	0.000249	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT2—malignant glioma	0.00012	0.000243	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—malignant glioma	0.00012	0.000242	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CD—malignant glioma	0.000116	0.000233	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000115	0.000231	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—KRAS—malignant glioma	0.000113	0.000228	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FGF2—malignant glioma	0.000111	0.000223	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—malignant glioma	0.000105	0.000211	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PIK3CA—malignant glioma	0.000104	0.00021	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MDM2—malignant glioma	0.000104	0.000209	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RAF1—malignant glioma	0.000103	0.000208	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ERBB2—malignant glioma	0.000102	0.000206	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CB—malignant glioma	0.000101	0.000203	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—malignant glioma	9.69e-05	0.000195	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—malignant glioma	9.37e-05	0.000189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP3—malignant glioma	9.28e-05	0.000187	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2—malignant glioma	9.27e-05	0.000187	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—malignant glioma	8.77e-05	0.000177	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTEN—malignant glioma	8.72e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—malignant glioma	8.5e-05	0.000171	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—malignant glioma	7.87e-05	0.000159	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—malignant glioma	7.8e-05	0.000157	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MYC—malignant glioma	7.24e-05	0.000146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—malignant glioma	7.09e-05	0.000143	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KRAS—malignant glioma	6.69e-05	0.000135	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PIK3CA—malignant glioma	6.15e-05	0.000124	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—malignant glioma	5.95e-05	0.00012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—malignant glioma	5.02e-05	0.000101	CbGpPWpGaD
